City National Bank’s Alnylam Pharmaceuticals ALNY Stock Holding History

City National Bank’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-29,424	Closed	-$3.53M	–	846
2015 Q2	$3.53M	Sell	29,424 -58,590	-67%	-$7M	0.03%	311
2015 Q1	$9.19M	Buy	88,014 +21,318	+32%	+$2.16M	0.08%	221
2014 Q4	$6.47M	Buy	66,696 +6,022	+10%	+$558K	0.06%	251
2014 Q3	$4.74M	Buy	60,674 +3,164	+6%	+$204K	0.04%	271
2014 Q2	$3.63M	Buy	57,510 +36,679	+176%	+$2.18M	0.03%	301
2014 Q1	$1.4M	Buy	20,831 +6,840	+49%	+$530K	0.02%	355
2013 Q4	$900K	Buy	13,991 +6,185	+79%	+$369K	0.01%	449
2013 Q3	$500K	Buy	+7,806	New	+$389K	0.01%	509

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

City National Bank's ALNY Position: Q3 2015 in Review

City National Bank sold out of Alnylam Pharmaceuticals (ALNY) in Q3 2015, closing a stake of 29,424 shares — an estimated $3.53M sold.

City National Bank first reported a position in ALNY in Q3 2013 and held it in 8 quarters. The position peaked at $9.19M in Q1 2015. 258 funds tracked by Wall St. Rank hold ALNY as of Q3 2015.

City National Bank reported no remaining Alnylam Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
City National Bank sold 29,424 Alnylam Pharmaceuticals shares in Q3 2015, an estimated $3.53M.
City National Bank first reported a position in Alnylam Pharmaceuticals in Q3 2013 and held it in 8 quarters.
City National Bank's Alnylam Pharmaceuticals position peaked at $9.19M in Q1 2015.
258 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2015.

Based on City National Bank's 13F filing for Q3 2015, filed 29 Oct 2015.